AZona
Posted - 3 days ago
$SNDX strong close 💪
Been here before tho 😅
Let’s see what next week brings 🙏
topstockalerts
Posted - 5 days ago
Pre Market Top Gainers $WW $CTCX $ALTM $SNDX $KZR
AlertsAndNews
Posted - 5 days ago
Good morning, gappers this morning include $WW $CTCX $ALTM $SNDX $BURU Lets get it!
AZona
Posted - 5 days ago
$SNDX 🤔
MewKitty
Posted - 6 days ago
$SNDX Anyone following this stock on this board? No activity.
jewell69
Posted - 1 week ago
$SNDX RE ENTRY 252 S ARES
QuantInsider
Posted - 1 week ago
Noticed something interesting with $SNDX lately—options volume has jumped up by 3.0x. That’s a pretty big spike and usually means some serious interest is brewing. Makes you wonder if the big players are gearing up for a move or if it’s just another day in the market. What do you all think? Could we be on the brink of something significant, or is it just typical market noise?
AZona
Posted - 1 week ago
$SNDX $25 then $30
Jarvis7424
Posted - 1 week ago
$SNDX so strong today 💪🏼
Jarvis7424
Posted - 09/30/24
$SNDX waiting for my $30 🎯
jewell69
Posted - 09/30/24
$SNDX 3/5/24 (6+ MOS) Syndax Pharmaceuticals Mar 05, 2024 Buy Reiterated $30.00 PT BACK ON 3/5: PRICE ABOUT 18.95 (58.81% Upside MS SALVEEN RIC_TER RECC IT.
jewell69
Posted - 09/30/24
$SNDX 09/30/2024 Sell Trade Details SNDX SYNDAX PHARMACEUTICALS I 251 $19.4482 $0.18 $4,881.32 09/26/2024 Buy Trade Details SNDX SYNDAX PHARMACEUTICALS I 251 $18.17 -$4,560.67 90 MINUTES LATER: 19.37
Jarvis7424
Posted - 09/25/24
$SNDX I’ll keep averaging down
jewell69
Posted - 09/24/24
$MTDR buyin 300 on a mkt on close; at time of order 52.15 last, b 52.12 o 52.18 took profits in $SNDX s today 9/24 18.2917 b 9/23 17.99 and s today $MGM 37.35 b 9/23 36.88 lookin 2 add 2 $SRPT down a lot, I am losin
jewell69
Posted - 09/23/24
09/23/2024 Buy Trade Details SNDX SYNDAX PHARMACEUTICALS I 250 $17.99 -$4,497.50 $SNDX BOT JUST NOW 2:33 PM edt
jewell69
Posted - 09/23/24
$SNDX 7/29 PT CUT AT STIFEL Target Price $42.00 $40.00 TRADES: 07/10/2024 Sell Trade Details SNDX SYNDAX PHARMACEUTICALS I 113 $22.61 $0.09 $2,554.84 07/01/2024 Sell Trade Details SNDX SYNDAX PHARMACEUTICALS I 90 $21.5801 $0.06 $1,942.15 05/13/2024 Buy Trade Details SNDX SYNDAX PHARMACEUTICALS I 90 $21.09 -$1,898.10 05/13/2024 Journaled Shares SNDX TDA TRAN - TRANSFER OF SECURITY OR OPTION OUT (SNDX) -113
Jarvis7424
Posted - 09/23/24
$SNDX this is insane
AZona
Posted - 09/23/24
$SNDX seems a bit oversold 😅
Bionical
Posted - 09/22/24
@GPS_OS_21_vs_SOC_5 I still find it mental how $REPL is 10x this marketcap and $sndx & $KURA are 20x ....
Bionical
Posted - 09/22/24
$SLS Sellas marketcap has been at $175million in early 2021 ... why would it be higher with less accomplishments? that's a very low number for a company with such a successful pipeline ... and that would be a 2.25x from here ... sounds like a lot? look at $SNDX or $KURA with their $1.5billion marketcaps ... SLS009 is outperforming their drugs! that would be a 20x from here .. and that's talking about the secondary asset, not even involving GPS ... $XBI
Night_Owl_Biotech
Posted - 09/20/24
The attachment notes shares prices over the last 13 weeks (3 months) of the XBI & the 7 commercial-stage oncology focused biopharmas with market caps between $1 & $5B. History suggests these are strong candidates for M&A. A table is also provided that shows market cap to enterprise value for all 7 (using 6/30/2024 balance sheet data where cash has likely been burned since). Also provided are current FY2026 analyst consensus revenue estimates sourced via Seeking Alpha. To the far right, FY2026 revenue multiples are provided. $IOVA & $SWTX trade at the lowest multiple of FY2026 revenue estimates (but were also launched sooner than the others excl IMCR). $IMCR recorded $75MM in Q224 revenues ($300MM annualized) & mgmt suggested Kimmtrak still has legs in mUM. This is not investment advice but IOVA's tail looks encouraging as does $DAWN $SNDX FY26 estimates may include contribution from Revumenib that is not approved yet (PDUFA = 12/26/24).
Stock_Titan
Posted - 09/18/24
$SNDX $INCY Incyte and Syndax Announce New England Journal of Medicine Publication of Data from Pivotal AGAVE-201 Trial of Niktimvo™ (axatilimab-csfr) in Chronic Graft-Versus-Host Disease
https://www.stocktitan.net/news/SNDX/incyte-and-syndax-announce-new-england-journal-of-medicine-11a0ohqr4enx.html
Jarvis7424
Posted - 09/18/24
$SNDX wtf?
Polip
Posted - 09/18/24
$SNDX are they diluting ATM?
Bionical
Posted - 09/17/24
@Engine444 @therightone $SLS with a marketcap of $1Billion (very reasonable and a lot lower than direct competitor $SNDX and $KURA for SLS009) would have the share price at $15.63 at current float.
When SLS gets acquired 136.6million shares total with warrants exercised .. MUCH lower than the 7-8x amount that $SMMT has .. a HUGE near 800million shares/warrants .. yet look at their price spike. I’m standing in front of a burning building offering you free fire insurance.
Bionical
Posted - 09/16/24
$SLS Pinned harder than a Wi-Fi password on a café chalkboard ... something be brewing. Marketcap should be 15x what it is right now based on SLS009 sofar in comparison to $SNDX and $KURA ... we've got two weeks left before news drops and this sends.
Bionical
Posted - 09/16/24
@JakeDelToro I think 1b is way too low a marketcap for a AML treatment halted for efficacy ... the company should be 1b just based on SLS009 sofar, look at its two competition drugs, $SNDX and $KURA ... also 1b would only be like $15 per share unless a lot more warrants get converted to shares
Aigner_Andreas
Posted - 1 month ago
#DeathCross $SNDX at 19.12 R7 HiLo 58% T1Y 31 buy 1.7 DIV N/A #Syndax Pha #stocks #trading #finance #market
Jarvis7424
Posted - 1 month ago
$SNDX fucking hell. No reason for this drop
MewKitty
Posted - 1 month ago
$SNDX IMHO, dead $$$ until 12/26. Seen this too often with good biotechs + good leadership, like SNDX. Long-term investors need a 2nd PDUFA approval to seal the deal + positive forward guidance from CEO/CFO re earnings. For the vast majority of microcap biotechs, profits or BOs drive SP, ECON 101. GLTA!